Synvitrobio, Inc.
Biotechnology company · San Leandro, California, United States
Synvitrobio, Inc. is a biotechnology company headquartered in San Leandro, California, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $753,071 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2023.
Synvitrobio at a glance
What does Synvitrobio do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $753,071 in total (2017 to 2020). NIH funding came from the National Human Genome Research Institute, National Center for Complementary and Integrative Health.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $17.6 million sold (2023).
Frequently asked questions about Synvitrobio
Where is Synvitrobio headquartered?
Synvitrobio, Inc. is headquartered in San Leandro, California, United States.
What does Synvitrobio do?
Synvitrobio, Inc. is a biotechnology company.
Similar companies
- Mercator Medsystems IncSan Leandro, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences